About Apotex Research Private Limited
Data last updated:
Apotex Research Private Limited is a private limited company based in Jigani Hobli, Karnataka, India, a subsidiary of Apotex Pharmaceuticals Holdings Inc.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2003PTC032103. Its GSTIN is 29AAECA2791B1ZU (Karnataka). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹460 Cr and a paid-up capital of ₹291.86 Cr. It is led by directors including Brian George Mcclelland and Goutam Vilas Pujari.
Its last annual general meeting (AGM) was held on 24 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Site No.1 Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Jigani Hobli, Karnataka, India – 562158.
As per the financials filed for FY 2025, the company reported a revenue of ₹727.34 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹76.62 Cr (net margin 10.5%) and EBITDA of ₹148.77 Cr (EBITDA margin 20.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
The company has about 1,236 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Apotex Pharmachem India and Apotex. As per MCA filings, the company has open charges of ₹483.8 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apotex.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressSite No.1 Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Jigani Hobli, Karnataka, India – 562158
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Apotex Research Private Limited
Apotex Research operates two associated brands: Apotex Pharmachem India and Apotex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. | apotex.co.in | |
| Generic pharmaceutical formulations are manufactured and exported by Apotex globally. | apotex.com |
Competitors & Alternatives of Apotex Research Private Limited
Brands and companies operating in the same space as Apotex Research Private Limited include Nephron Pharmaceuticals, Suanfarma, Enzene Biosciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Nephron Pharmaceuticals | Sterile pharmaceutical products are manufactured and contract services are provided. | Florida, Puerto Rico, United States | 1937 |
 Suanfarma | Generics, nutraceuticals, and APIs are developed by Suanfarma. | Madrid, Spain | 1993 |
 Enzene Biosciences | Company specializing in development of Biosimilars | Pune, India | 2006 |
 Quotient Sciences | APIs and finished dosage forms are developed and manufactured. | Nottingham, United Kingdom | 1990 |
 Hybio Pharmaceutical | Polypeptide drugs and APIs are developed and manufactured. | Shenzhen, China | 1998 |
 Aiolos Bio | Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions | Boston, United States | 2023 |
 Kardigan | Biotech company developing personalized medicines for cardiovascular diseases | San Francisco, United States | 2023 |
 AmbioPharm | CDMO and analytical services for peptide development are provided. | North Augusta, United States | 2006 |
Business Activity of Apotex Research Private Limited
The main business activities of Apotex Research are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Apotex Research Private Limited
Apotex Research Private Limited is audited by Haribhakti & Co. LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Haribhakti & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Apotex Research Private Limited
Apotex Research has 4 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brian George Mcclelland Also directs: Apotex Pharmachem India Private Limited | Director | 15 Sep 2023 | 3 Years 0 Months | Current |
| Rajesh Salwan | Additional Director | 18 Mar 2025 | 1 Years 6 Months | Current |
| Goutam Vilas Pujari | Director | 01 Dec 2018 | 7 Years 10 Months | Current |
| Uta Kellermann Renton Also directs: Apotex Pharmachem India Private Limited | Additional Director | 18 Mar 2025 | 1 Years 6 Months | Current |
Financials of Apotex Research Private Limited FY 2024 filings available
Apotex Research Private Limited reported revenue of ₹727.34 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Apotex Research Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 22% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Apotex Research Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹148.77 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹76.62 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Apotex Research Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apotex Research are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Apotex Research Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Apotex Research Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2023 | Others | ₹30 Cr | Open |
| 09 Jun 2017 | Others | ₹5 Cr | Open |
| 24 Mar 2016 | The Hongkong and Shanghai Banking Corporation Limited | ₹80 Lakh | Open |
| 17 Oct 2012 | The Hongkong and Shanghai Banking Corporation Limited | ₹198 Cr | Open |
| 31 Mar 2006 | Apotex Pharmaceutical Holdings Inc | ₹250 Cr | Open |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Apotex Research Private Limited
Apotex Research Private Limited has a workforce of 1,236 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Apotex Research Private Limited
Apotex Research has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECA2791B1ZU | Karnataka | Active | 01 Jul 2017 |
| 29AAECA2791B2ZT | Karnataka | Active | 21 Mar 2025 |
| 27AAECA2791B1ZY | Maharashtra | Active | 09 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Apotex Research Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apotex Research Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apotex Research Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apotex Research Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Apotex Research Private Limited
Recent News on Apotex Research Private Limited
Frequently Asked Questions about Apotex Research Private Limited
Apotex Research is an active private limited company based in Jigani Hobli, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 June 2003 (23+ years old) and is registered under CIN U73100KA2003PTC032103.
Apotex Research reported revenue of ₹727.34 Cr for FY 2025 (up 22% YoY).
Apotex Research has 4 current directors:
- Brian George Mcclelland - Director
- Rajesh Salwan - Additional Director
- Goutam Vilas Pujari - Director
- Uta Kellermann Renton - Additional Director
Apotex Research reported a net profit of ₹76.62 Cr (net margin 10.5%) and EBITDA of ₹148.77 Cr (EBITDA margin 20.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Apotex Research is 10% over three years and 3% over five years. In the latest year (FY 2025) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Apotex Research is 29AAECA2791B1ZU, registered in Karnataka. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 29AAECA2791B2ZT (Karnataka), 27AAECA2791B1ZY (Maharashtra).
The CIN (Corporate Identification Number) of Apotex Research is U73100KA2003PTC032103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apotex Research was incorporated on 16 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Bangalore.
Apotex Research can be reached through the website apotex.com. Its registered office is in Jigani Hobli, Karnataka, India.